Santos Susana Constantino Rosa, Miguel Cláudia, Domingues Ines, Calado Angelo, Zhu Zhenping, Wu Yan, Dias Sérgio
Angiogenesis Laboratory, Centro de Investigação em Patobiologia Molecular, Instituto Português de Oncologia Francisco Gentil-CROL, SA, Lisboa, Portugal.
Exp Cell Res. 2007 May 1;313(8):1561-74. doi: 10.1016/j.yexcr.2007.02.020. Epub 2007 Mar 1.
Vascular endothelial growth factor (VEGF) receptor activation regulates endothelial cell (EC) survival, migration and proliferation. Recently, it was suggested the cross-talk between the VEGF receptors-1 (FLT-1) and -2 (KDR) modulated several of these functions, but the detailed molecular basis for such interactions remained unexplained. Here we demonstrate for the first time that VEGF stimulation of EC monolayers induced a rapid FLT-1-mediated internalization of KDR to the nucleus, via microtubules and the endocytic pathway, internalization which required the activation of PI 3-kinase/AKT. KDR deletion mutants were generated in several tyrosine residues; in these, VEGF-induced KDR internalization was impaired, demonstrating this process required activation (phosphorylation) of the receptor. Furthermore, we demonstrate that in vitro wounding of EC monolayers leads to a rapid and transient internalization of VEGF+KDR to the nucleus, which is essential for monolayer recovery. Notably, FLT-1 blockade impedes VEGF and KDR activation and internalization, blocking endothelial monolayer recovery. Our data reveal a previously unrecognized mechanism induced by VEGF on EC, which regulates EC recovery following wounding, and as such indicate novel targets for therapeutic intervention.
血管内皮生长因子(VEGF)受体激活可调节内皮细胞(EC)的存活、迁移和增殖。最近,有人提出VEGF受体-1(FLT-1)和-2(KDR)之间的相互作用调节了其中一些功能,但这种相互作用的详细分子基础仍不清楚。在这里,我们首次证明,VEGF刺激EC单层细胞可通过微管和内吞途径诱导KDR由FLT-1介导迅速内化至细胞核,这种内化需要PI 3激酶/AKT的激活。在几个酪氨酸残基处产生了KDR缺失突变体;在这些突变体中,VEGF诱导的KDR内化受损,表明该过程需要受体的激活(磷酸化)。此外,我们证明,体外对EC单层细胞造成损伤会导致VEGF+KDR迅速且短暂地内化至细胞核,这对单层细胞的恢复至关重要。值得注意的是,FLT-1阻断会阻碍VEGF和KDR的激活及内化,从而阻止内皮单层细胞的恢复。我们的数据揭示了VEGF在EC上诱导的一种以前未被认识的机制,该机制调节损伤后EC的恢复,因此指出了治疗干预的新靶点。